Concepts (369)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonoscopy | 20 | 2021 | 1409 | 3.580 |
Why?
|
| Gastrostomy | 9 | 2011 | 325 | 1.630 |
Why?
|
| Colonic Diseases | 5 | 2015 | 204 | 1.470 |
Why?
|
| Gastrointestinal Hemorrhage | 7 | 2022 | 1126 | 1.350 |
Why?
|
| Colitis, Ischemic | 4 | 2018 | 32 | 1.180 |
Why?
|
| Ascites | 4 | 2019 | 336 | 1.040 |
Why?
|
| Hemostasis, Endoscopic | 2 | 2022 | 42 | 0.990 |
Why?
|
| Private Practice | 2 | 2021 | 154 | 0.880 |
Why?
|
| Cholangitis | 4 | 2008 | 110 | 0.860 |
Why?
|
| Bile Ducts | 4 | 2014 | 288 | 0.860 |
Why?
|
| Endoscopy, Gastrointestinal | 6 | 2009 | 888 | 0.790 |
Why?
|
| Peritonitis | 5 | 2011 | 368 | 0.770 |
Why?
|
| Portal Vein | 3 | 2014 | 437 | 0.740 |
Why?
|
| Bariatrics | 1 | 2021 | 36 | 0.710 |
Why?
|
| Colitis | 5 | 2019 | 1238 | 0.700 |
Why?
|
| Intestinal Polyps | 3 | 2013 | 105 | 0.680 |
Why?
|
| Esophageal Stenosis | 1 | 2021 | 196 | 0.650 |
Why?
|
| Career Mobility | 1 | 2021 | 262 | 0.640 |
Why?
|
| Liver Cirrhosis | 3 | 2024 | 1959 | 0.640 |
Why?
|
| Colonic Neoplasms | 6 | 2020 | 2535 | 0.630 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2019 | 186 | 0.610 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2024 | 1243 | 0.600 |
Why?
|
| Intestinal Mucosa | 8 | 2013 | 3043 | 0.580 |
Why?
|
| Gastric Mucosa | 4 | 2006 | 602 | 0.570 |
Why?
|
| Ulcer | 1 | 2018 | 203 | 0.560 |
Why?
|
| Endoscopy, Digestive System | 6 | 2011 | 358 | 0.560 |
Why?
|
| Intestinal Fistula | 2 | 2011 | 146 | 0.560 |
Why?
|
| Endoscopy | 8 | 2021 | 1854 | 0.560 |
Why?
|
| Cathartics | 2 | 2011 | 129 | 0.550 |
Why?
|
| Intestinal Perforation | 4 | 2006 | 254 | 0.540 |
Why?
|
| Laser Coagulation | 3 | 2006 | 335 | 0.540 |
Why?
|
| Thumb | 1 | 2018 | 232 | 0.520 |
Why?
|
| Esophageal Diseases | 1 | 2016 | 167 | 0.500 |
Why?
|
| Colorectal Neoplasms | 7 | 2021 | 6966 | 0.490 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2016 | 52 | 0.490 |
Why?
|
| Intestinal Obstruction | 3 | 2006 | 433 | 0.490 |
Why?
|
| Peptic Ulcer | 1 | 2016 | 214 | 0.480 |
Why?
|
| Career Choice | 1 | 2021 | 769 | 0.480 |
Why?
|
| Night Care | 1 | 2015 | 28 | 0.480 |
Why?
|
| Cecum | 2 | 2018 | 231 | 0.460 |
Why?
|
| Teaching | 1 | 2021 | 1172 | 0.450 |
Why?
|
| Ampulla of Vater | 3 | 2003 | 150 | 0.430 |
Why?
|
| Hepatolenticular Degeneration | 4 | 1995 | 73 | 0.420 |
Why?
|
| Phlebitis | 1 | 2013 | 34 | 0.420 |
Why?
|
| Faculty, Medical | 1 | 2021 | 1227 | 0.420 |
Why?
|
| Amanita | 1 | 2012 | 2 | 0.410 |
Why?
|
| Mushroom Poisoning | 1 | 2012 | 5 | 0.410 |
Why?
|
| Mesenteric Veins | 1 | 2013 | 87 | 0.410 |
Why?
|
| Duodenum | 2 | 2007 | 495 | 0.400 |
Why?
|
| Adenomatous Polyps | 1 | 2013 | 109 | 0.390 |
Why?
|
| Gastroesophageal Reflux | 3 | 2008 | 834 | 0.390 |
Why?
|
| Deglutition Disorders | 2 | 2016 | 640 | 0.380 |
Why?
|
| Lipoma | 2 | 2006 | 294 | 0.370 |
Why?
|
| Esophageal and Gastric Varices | 2 | 2005 | 215 | 0.370 |
Why?
|
| Laparoscopy | 1 | 2023 | 2037 | 0.370 |
Why?
|
| Stomach Ulcer | 1 | 2011 | 118 | 0.370 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 998 | 0.360 |
Why?
|
| Sphincterotomy, Endoscopic | 3 | 2003 | 44 | 0.360 |
Why?
|
| Arteriovenous Malformations | 2 | 2006 | 396 | 0.350 |
Why?
|
| Colonoscopes | 2 | 2020 | 17 | 0.350 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 6 | 2005 | 520 | 0.350 |
Why?
|
| Gastric Fistula | 1 | 2011 | 73 | 0.350 |
Why?
|
| Scleroderma, Systemic | 3 | 2002 | 346 | 0.350 |
Why?
|
| Humans | 115 | 2024 | 767040 | 0.350 |
Why?
|
| Enteral Nutrition | 4 | 2007 | 802 | 0.350 |
Why?
|
| Anti-Ulcer Agents | 2 | 2005 | 112 | 0.350 |
Why?
|
| Gallstones | 3 | 2008 | 285 | 0.350 |
Why?
|
| Glutaral | 1 | 2010 | 78 | 0.350 |
Why?
|
| Ileal Neoplasms | 1 | 2009 | 20 | 0.340 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 1293 | 0.340 |
Why?
|
| Gastric Outlet Obstruction | 2 | 2000 | 55 | 0.340 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2010 | 93 | 0.330 |
Why?
|
| Colitis, Ulcerative | 3 | 2009 | 1924 | 0.330 |
Why?
|
| Peristalsis | 2 | 2008 | 60 | 0.320 |
Why?
|
| Disinfectants | 1 | 2010 | 131 | 0.310 |
Why?
|
| Liver Transplantation | 3 | 2013 | 2416 | 0.300 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2001 | 166 | 0.300 |
Why?
|
| Carcinoid Tumor | 1 | 2009 | 225 | 0.300 |
Why?
|
| Sleep Deprivation | 1 | 2015 | 848 | 0.290 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2008 | 54 | 0.290 |
Why?
|
| CA-19-9 Antigen | 1 | 2008 | 109 | 0.290 |
Why?
|
| Ultrasonography, Doppler | 1 | 2010 | 463 | 0.290 |
Why?
|
| Esophagus | 3 | 2008 | 1041 | 0.290 |
Why?
|
| Duodenal Neoplasms | 1 | 2008 | 114 | 0.290 |
Why?
|
| Hepatic Veins | 1 | 2007 | 112 | 0.280 |
Why?
|
| Colonic Polyps | 2 | 2010 | 557 | 0.280 |
Why?
|
| Bile Duct Neoplasms | 2 | 2005 | 614 | 0.280 |
Why?
|
| Embolism, Air | 1 | 2007 | 111 | 0.280 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2006 | 640 | 0.270 |
Why?
|
| Liver Neoplasms | 2 | 2016 | 4357 | 0.260 |
Why?
|
| Blood Loss, Surgical | 1 | 2010 | 642 | 0.260 |
Why?
|
| Medically Uninsured | 1 | 2012 | 838 | 0.260 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 812 | 0.260 |
Why?
|
| Omeprazole | 2 | 2005 | 106 | 0.260 |
Why?
|
| Pancreatitis | 2 | 2003 | 1087 | 0.260 |
Why?
|
| Neoplasm Seeding | 1 | 2006 | 85 | 0.260 |
Why?
|
| Adenoma | 2 | 2020 | 2155 | 0.250 |
Why?
|
| Esophageal Motility Disorders | 2 | 1998 | 49 | 0.250 |
Why?
|
| Stents | 3 | 2006 | 3193 | 0.250 |
Why?
|
| Esophagoscopes | 1 | 2005 | 16 | 0.250 |
Why?
|
| Colon | 3 | 2018 | 1797 | 0.240 |
Why?
|
| Gases | 2 | 2003 | 205 | 0.240 |
Why?
|
| Lymphocytes | 1 | 2013 | 2605 | 0.240 |
Why?
|
| Cyanoacrylates | 1 | 2005 | 47 | 0.240 |
Why?
|
| Cholestasis, Extrahepatic | 2 | 2003 | 52 | 0.230 |
Why?
|
| Abdominal Wall | 1 | 2006 | 166 | 0.230 |
Why?
|
| Abdominal Neoplasms | 1 | 2006 | 286 | 0.230 |
Why?
|
| Venous Thrombosis | 1 | 2014 | 1321 | 0.230 |
Why?
|
| Blood Coagulation | 1 | 2010 | 1163 | 0.230 |
Why?
|
| Choristoma | 1 | 2006 | 205 | 0.230 |
Why?
|
| Hepatitis | 2 | 1996 | 226 | 0.230 |
Why?
|
| Clinical Competence | 2 | 2023 | 4859 | 0.230 |
Why?
|
| Foreign-Body Migration | 1 | 2006 | 220 | 0.230 |
Why?
|
| Ileocecal Valve | 1 | 2003 | 22 | 0.230 |
Why?
|
| Biliary Fistula | 1 | 2004 | 38 | 0.230 |
Why?
|
| Thiazoles | 2 | 2002 | 1530 | 0.220 |
Why?
|
| Intestine, Small | 3 | 2006 | 1217 | 0.220 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2005 | 304 | 0.220 |
Why?
|
| Barotrauma | 1 | 2003 | 41 | 0.210 |
Why?
|
| Gallbladder Diseases | 1 | 2004 | 139 | 0.210 |
Why?
|
| Biliary Tract | 1 | 2003 | 136 | 0.200 |
Why?
|
| Metals | 3 | 2006 | 711 | 0.200 |
Why?
|
| Duodenal Diseases | 1 | 2003 | 101 | 0.200 |
Why?
|
| Common Bile Duct Diseases | 1 | 2002 | 36 | 0.200 |
Why?
|
| Pneumoperitoneum | 1 | 2002 | 46 | 0.200 |
Why?
|
| Duodenoscopy | 1 | 2002 | 45 | 0.200 |
Why?
|
| Celiac Disease | 2 | 2001 | 821 | 0.200 |
Why?
|
| Biliary Tract Diseases | 1 | 2002 | 159 | 0.190 |
Why?
|
| Bile | 1 | 2002 | 300 | 0.190 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 1104 | 0.190 |
Why?
|
| Magnesium Deficiency | 1 | 2001 | 48 | 0.190 |
Why?
|
| Zinc | 3 | 1995 | 675 | 0.190 |
Why?
|
| Octreotide | 1 | 2002 | 156 | 0.190 |
Why?
|
| Thiazines | 1 | 2001 | 38 | 0.190 |
Why?
|
| Anion Exchange Resins | 1 | 2001 | 10 | 0.190 |
Why?
|
| Cholestyramine Resin | 1 | 2001 | 25 | 0.190 |
Why?
|
| Mallory-Weiss Syndrome | 1 | 2000 | 2 | 0.180 |
Why?
|
| Diagnosis, Differential | 9 | 2010 | 12986 | 0.180 |
Why?
|
| Device Removal | 1 | 2006 | 643 | 0.180 |
Why?
|
| Colonic Pseudo-Obstruction | 1 | 2000 | 7 | 0.180 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2024 | 205 | 0.180 |
Why?
|
| Bilirubin | 1 | 2002 | 440 | 0.180 |
Why?
|
| Hypokalemia | 1 | 2001 | 152 | 0.180 |
Why?
|
| Retropneumoperitoneum | 1 | 2000 | 4 | 0.180 |
Why?
|
| Gastroscopy | 2 | 2001 | 213 | 0.180 |
Why?
|
| Peritoneovenous Shunt | 1 | 2019 | 9 | 0.170 |
Why?
|
| Jaundice | 1 | 2000 | 95 | 0.170 |
Why?
|
| Hypocalcemia | 1 | 2001 | 205 | 0.170 |
Why?
|
| Escherichia coli O157 | 1 | 2000 | 53 | 0.170 |
Why?
|
| Liver Failure | 1 | 2002 | 252 | 0.170 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2019 | 40 | 0.170 |
Why?
|
| Quality of Health Care | 1 | 2015 | 4306 | 0.170 |
Why?
|
| Mesalamine | 1 | 2000 | 133 | 0.160 |
Why?
|
| Ascitic Fluid | 1 | 2019 | 189 | 0.160 |
Why?
|
| Water Microbiology | 1 | 2000 | 117 | 0.160 |
Why?
|
| Cholangiocarcinoma | 1 | 2005 | 561 | 0.160 |
Why?
|
| Dilatation | 1 | 2021 | 311 | 0.160 |
Why?
|
| Pharyngeal Diseases | 1 | 2000 | 134 | 0.160 |
Why?
|
| Nutritional Support | 1 | 2001 | 178 | 0.160 |
Why?
|
| Diverticulitis | 1 | 2002 | 187 | 0.160 |
Why?
|
| Air | 1 | 1999 | 186 | 0.160 |
Why?
|
| Diverticulum | 1 | 2020 | 137 | 0.160 |
Why?
|
| Budd-Chiari Syndrome | 1 | 1999 | 24 | 0.160 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1999 | 62 | 0.160 |
Why?
|
| Mass Screening | 2 | 2013 | 5456 | 0.160 |
Why?
|
| Hemostasis, Surgical | 1 | 1999 | 128 | 0.160 |
Why?
|
| Thiazolidinediones | 1 | 2002 | 460 | 0.160 |
Why?
|
| Aeromonas | 1 | 1998 | 17 | 0.160 |
Why?
|
| Polyethylene Glycols | 2 | 2006 | 1188 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7871 | 0.150 |
Why?
|
| Trientine | 2 | 1995 | 12 | 0.150 |
Why?
|
| Ecchymosis | 1 | 1998 | 32 | 0.150 |
Why?
|
| Photochemotherapy | 1 | 2005 | 828 | 0.150 |
Why?
|
| Esophageal Achalasia | 1 | 1999 | 98 | 0.150 |
Why?
|
| Colitis, Microscopic | 1 | 2019 | 72 | 0.150 |
Why?
|
| Penicillamine | 2 | 1995 | 60 | 0.150 |
Why?
|
| Thorax | 1 | 2001 | 556 | 0.150 |
Why?
|
| Cellulitis | 1 | 2000 | 206 | 0.150 |
Why?
|
| Enterochromaffin Cells | 1 | 1997 | 12 | 0.150 |
Why?
|
| Mesenteric Arteries | 2 | 2010 | 177 | 0.150 |
Why?
|
| Dinoprostone | 1 | 2020 | 597 | 0.140 |
Why?
|
| Pancreas | 2 | 2009 | 1699 | 0.140 |
Why?
|
| Gastric Acid | 1 | 1997 | 98 | 0.140 |
Why?
|
| Gastrointestinal Agents | 1 | 2002 | 511 | 0.140 |
Why?
|
| Jejunostomy | 1 | 1997 | 61 | 0.140 |
Why?
|
| Blastocystis hominis | 1 | 1996 | 6 | 0.140 |
Why?
|
| Laryngeal Diseases | 1 | 2000 | 248 | 0.140 |
Why?
|
| Blastocystis Infections | 1 | 1996 | 17 | 0.140 |
Why?
|
| Duodenal Ulcer | 1 | 1997 | 117 | 0.140 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 1156 | 0.140 |
Why?
|
| Stomach | 1 | 2001 | 701 | 0.140 |
Why?
|
| Listeriosis | 2 | 1995 | 147 | 0.130 |
Why?
|
| Proctocolitis | 1 | 1996 | 31 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2270 | 0.130 |
Why?
|
| Sigmoid Diseases | 1 | 1996 | 61 | 0.130 |
Why?
|
| Serum Albumin | 1 | 2019 | 676 | 0.130 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 1998 | 238 | 0.130 |
Why?
|
| Helicobacter pylori | 1 | 1999 | 380 | 0.130 |
Why?
|
| Escherichia coli Infections | 1 | 2000 | 518 | 0.130 |
Why?
|
| Helicobacter Infections | 1 | 1999 | 390 | 0.130 |
Why?
|
| Drug Monitoring | 2 | 2000 | 963 | 0.130 |
Why?
|
| Radiography, Abdominal | 1 | 1999 | 542 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 7435 | 0.130 |
Why?
|
| Ceruloplasmin | 2 | 1992 | 57 | 0.130 |
Why?
|
| DNA Probes | 1 | 1996 | 541 | 0.120 |
Why?
|
| Esophagitis, Peptic | 1 | 1996 | 77 | 0.120 |
Why?
|
| Decompression, Surgical | 1 | 2000 | 603 | 0.120 |
Why?
|
| Foreign Bodies | 1 | 1999 | 403 | 0.120 |
Why?
|
| Vegetables | 1 | 2020 | 1199 | 0.120 |
Why?
|
| Pelvis | 1 | 1999 | 736 | 0.120 |
Why?
|
| Azathioprine | 1 | 1996 | 354 | 0.120 |
Why?
|
| Esophageal Neoplasms | 1 | 2005 | 1661 | 0.120 |
Why?
|
| Carcinoma in Situ | 2 | 1997 | 784 | 0.120 |
Why?
|
| Ischemia | 1 | 2003 | 1905 | 0.110 |
Why?
|
| Catheterization | 1 | 1999 | 1430 | 0.110 |
Why?
|
| Diarrhea | 1 | 2001 | 1319 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 2 | 2003 | 5446 | 0.110 |
Why?
|
| Autoimmune Diseases | 2 | 1996 | 2255 | 0.110 |
Why?
|
| Male | 25 | 2020 | 364203 | 0.110 |
Why?
|
| Emergencies | 1 | 1999 | 1223 | 0.110 |
Why?
|
| Middle Aged | 22 | 2020 | 223233 | 0.100 |
Why?
|
| Hydrocephalus | 1 | 2019 | 766 | 0.100 |
Why?
|
| Liver | 2 | 2007 | 7578 | 0.100 |
Why?
|
| Endosonography | 2 | 2009 | 626 | 0.100 |
Why?
|
| Adenocarcinoma | 2 | 2000 | 6360 | 0.100 |
Why?
|
| Female | 28 | 2020 | 396660 | 0.100 |
Why?
|
| Aged | 17 | 2020 | 171319 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2000 | 1172 | 0.100 |
Why?
|
| Decision Making | 2 | 2021 | 3951 | 0.100 |
Why?
|
| Liver Function Tests | 2 | 2005 | 526 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2003 | 1759 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2000 | 1161 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 1 | 2006 | 2930 | 0.090 |
Why?
|
| Argon Plasma Coagulation | 1 | 2011 | 26 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 2783 | 0.090 |
Why?
|
| Sepsis | 1 | 2005 | 2605 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 2000 | 1761 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2000 | 1804 | 0.090 |
Why?
|
| Risk Assessment | 7 | 2006 | 24299 | 0.080 |
Why?
|
| Ambulatory Care | 1 | 2000 | 2780 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2023 | 6260 | 0.080 |
Why?
|
| Intubation | 1 | 2009 | 140 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2007 | 5519 | 0.080 |
Why?
|
| Hepacivirus | 1 | 1996 | 1342 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 3108 | 0.080 |
Why?
|
| Hepatitis C | 2 | 1996 | 1594 | 0.080 |
Why?
|
| Critical Illness | 1 | 2001 | 2753 | 0.080 |
Why?
|
| Follow-Up Studies | 6 | 2006 | 39317 | 0.080 |
Why?
|
| Aspirin | 1 | 2020 | 3135 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 1997 | 1390 | 0.080 |
Why?
|
| Retreatment | 2 | 2000 | 598 | 0.080 |
Why?
|
| Prosthesis Failure | 2 | 2006 | 1208 | 0.070 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2008 | 26 | 0.070 |
Why?
|
| RNA, Viral | 1 | 1996 | 2867 | 0.070 |
Why?
|
| Klebsiella Infections | 1 | 2009 | 146 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2011 | 15824 | 0.070 |
Why?
|
| Adult | 15 | 2020 | 223317 | 0.070 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2008 | 100 | 0.070 |
Why?
|
| Gangrene | 1 | 2007 | 92 | 0.070 |
Why?
|
| Ileum | 1 | 2009 | 558 | 0.070 |
Why?
|
| Crohn Disease | 1 | 1999 | 2295 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 6067 | 0.070 |
Why?
|
| Interferon-alpha | 2 | 2006 | 909 | 0.070 |
Why?
|
| Pancreatic Diseases | 1 | 2009 | 354 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2007 | 20741 | 0.070 |
Why?
|
| Recurrence | 3 | 2005 | 8504 | 0.060 |
Why?
|
| Torsion Abnormality | 1 | 2006 | 92 | 0.060 |
Why?
|
| Cholecystectomy | 1 | 2008 | 408 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2007 | 9362 | 0.060 |
Why?
|
| Abscess | 1 | 2009 | 606 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2000 | 2441 | 0.060 |
Why?
|
| Argon | 1 | 2005 | 36 | 0.060 |
Why?
|
| Hepatitis, Chronic | 2 | 1996 | 53 | 0.060 |
Why?
|
| Acute Disease | 2 | 2008 | 7236 | 0.060 |
Why?
|
| Equipment Design | 2 | 2005 | 3489 | 0.060 |
Why?
|
| Ribavirin | 1 | 2006 | 395 | 0.060 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2008 | 515 | 0.060 |
Why?
|
| Manometry | 2 | 1999 | 458 | 0.060 |
Why?
|
| Genetic Variation | 1 | 1998 | 6611 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 13650 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 4210 | 0.050 |
Why?
|
| Injections | 1 | 2006 | 839 | 0.050 |
Why?
|
| Administration, Oral | 3 | 2009 | 4026 | 0.050 |
Why?
|
| Interleukin-13 | 1 | 2024 | 391 | 0.050 |
Why?
|
| Laparotomy | 1 | 2004 | 459 | 0.050 |
Why?
|
| Gallbladder Emptying | 1 | 2001 | 14 | 0.050 |
Why?
|
| Hepatectomy | 1 | 2005 | 589 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 14672 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2011 | 1804 | 0.040 |
Why?
|
| Administration, Rectal | 1 | 2000 | 69 | 0.040 |
Why?
|
| Hamartoma | 1 | 2002 | 235 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2006 | 1141 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2001 | 5311 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2005 | 551 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2001 | 585 | 0.040 |
Why?
|
| Pancreatectomy | 1 | 2003 | 825 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 15925 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 1205 | 0.040 |
Why?
|
| Esophagogastric Junction | 1 | 2000 | 350 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2007 | 21178 | 0.040 |
Why?
|
| Hepatitis C, Chronic | 1 | 2006 | 1032 | 0.040 |
Why?
|
| Embolization, Therapeutic | 1 | 2007 | 1403 | 0.040 |
Why?
|
| Parietal Cells, Gastric | 1 | 1997 | 39 | 0.040 |
Why?
|
| Gastrins | 1 | 1997 | 75 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2001 | 54886 | 0.040 |
Why?
|
| New York | 1 | 2000 | 879 | 0.040 |
Why?
|
| Wounds, Penetrating | 1 | 1999 | 316 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2006 | 2252 | 0.030 |
Why?
|
| Risk Factors | 5 | 2006 | 74886 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 1615 | 0.030 |
Why?
|
| Sarcoma | 1 | 2008 | 1802 | 0.030 |
Why?
|
| Cisapride | 1 | 1996 | 22 | 0.030 |
Why?
|
| Prevalence | 2 | 2020 | 15851 | 0.030 |
Why?
|
| Abdomen | 1 | 2002 | 1138 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 59548 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2002 | 1540 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 40154 | 0.030 |
Why?
|
| Steroids | 1 | 2000 | 937 | 0.030 |
Why?
|
| Fruit | 1 | 2020 | 1165 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2009 | 65295 | 0.030 |
Why?
|
| Syndrome | 1 | 2001 | 3271 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 3488 | 0.030 |
Why?
|
| Biopsy | 2 | 1998 | 6777 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2006 | 3070 | 0.030 |
Why?
|
| Metallothionein | 1 | 1993 | 62 | 0.030 |
Why?
|
| Zinc Sulfate | 1 | 1992 | 18 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 1508 | 0.030 |
Why?
|
| Copper Radioisotopes | 1 | 1992 | 99 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2006 | 6310 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 1992 | 172 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2024 | 3582 | 0.020 |
Why?
|
| Sulfates | 1 | 1992 | 379 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 7469 | 0.020 |
Why?
|
| Copper | 1 | 1992 | 365 | 0.020 |
Why?
|
| Klebsiella oxytoca | 1 | 2009 | 7 | 0.020 |
Why?
|
| Wound Healing | 1 | 2000 | 2800 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10748 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 3530 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1993 | 2478 | 0.020 |
Why?
|
| Survival Rate | 1 | 2002 | 12823 | 0.020 |
Why?
|
| Hepatitis B | 1 | 1993 | 710 | 0.020 |
Why?
|
| Piperidines | 1 | 1996 | 1667 | 0.020 |
Why?
|
| Klebsiella pneumoniae | 1 | 2009 | 253 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1996 | 1883 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12451 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1993 | 1794 | 0.020 |
Why?
|
| Psoriasis | 1 | 1993 | 925 | 0.020 |
Why?
|
| Inflammation | 1 | 2024 | 10869 | 0.010 |
Why?
|
| Intestines | 1 | 1993 | 1905 | 0.010 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2009 | 1131 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14766 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1993 | 6331 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 13491 | 0.010 |
Why?
|
| New England | 1 | 2006 | 1058 | 0.010 |
Why?
|
| Diet | 1 | 2020 | 8089 | 0.010 |
Why?
|
| Prognosis | 1 | 2002 | 29963 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 89046 | 0.010 |
Why?
|
| Rats | 1 | 1997 | 23713 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 3431 | 0.010 |
Why?
|
| Age Factors | 1 | 1996 | 18401 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26325 | 0.010 |
Why?
|
| Genetic Testing | 1 | 1992 | 3591 | 0.010 |
Why?
|
| Child | 1 | 2007 | 80771 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2002 | 12250 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6507 | 0.010 |
Why?
|
| Animals | 2 | 1997 | 168965 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 59980 | 0.010 |
Why?
|
| Ampicillin | 1 | 1992 | 137 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 13284 | 0.010 |
Why?
|
Concepts
(369)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_